Dickson Data is back at it. On Thursday it released a new infographic [below] showing which drug patents are set to expire in 2017. It follows the template of its popular 2016 infographic, which ...

The news of Bruce Jenner's recent transgender surgery has taken this previously private surgery to the public mainstream. “Transgender surgery is certainly not new, but Bruce's journey to Caitlyn has ...

The heavily scrutinized 340B Drug Pricing Program is back in the spotlight as the Trump administration targets drug costs in a recent Executive Order. The 340B Drug Pricing Program has received a lot ...

In a recent analysis of HRSA data, the American Hospital Association has turned the tables on drug companies and accused them of being far more likely to violate 340B Drug Pricing Program rules. In ...

Prescription drugs are still in the dark ages, but as we wait for science to catch up, smart modeling predicts problems before they happen. That’s a question that a team of scientists from the UCSF ...

Listen with Speechify 0:00 1:00 By Edyta Zielinska Please download the Adobe Flash Player to view this content: Diverting a Diet Drug The Good Fat The Future of the FDA The Trouble with Tech Transfer ...

The Food and Drug Administration has halved its approval time for new drugs since 2009, as illustrated in a colorful new infographic from the California Life Sciences Association and Boston Consulting ...

Forbes contributors publish independent expert analyses and insights. We are a global business consulting firm. New drug launches face more intense competition than a decade ago: 50% of drug launches ...

America's drug crisis is getting worse. According to newly published figures from the Centers for Disease Control and Prevention, there were 70,237 deaths from drug overdoses across the United States ...

Researchers from Tufts Medical Center analyzed findings from 26 studies to determine how drug exclusion policies affect patients and healthcare costs. At the beginning of August, Express Scripts and ...

Plasmodium falciparum resistance to artemisinin-based combination therapies (ACTs) started to crop up around 2007. Infections, especially in the Greater Mekong area of Southeast Asia, seemingly ...